APG Asset Management US’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-15,015
Closed -$12.4M 121
2025
Q3
$12.4M Buy
15,015
+98
+0.7% +$72.9K 0.09% 52
2025
Q2
$11.6M Hold
14,917
0.09% 51
2025
Q1
$12M Hold
14,917
0.09% 52
2024
Q4
$11.5M Buy
14,917
+1,554
+12% +$1.29M 0.09% 52
2024
Q3
$11.8M Sell
13,363
-190,965
-93% -$172M 0.08% 52
2024
Q2
$187M Buy
204,328
+1,586
+0.8% +$1.27M 1.07% 22
2024
Q1
$154M Buy
202,742
+63,837
+46% +$45.4M 0.89% 25
2023
Q4
$81M Buy
+138,905
New +$81.1M 0.5% 30

Other funds holding LLY

APG Asset Management US's LLY Position: Q4 2025 in Review

APG Asset Management US sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 15,015 shares — an estimated $12.4M sold.

APG Asset Management US first reported a position in LLY in Q4 2023 and held it in 8 quarters. The position peaked at $187M in Q2 2024. 4,441 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • APG Asset Management US reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
  • APG Asset Management US sold 15,015 Eli Lilly shares in Q4 2025, an estimated $12.4M.
  • APG Asset Management US first reported a position in Eli Lilly in Q4 2023 and held it in 8 quarters.
  • APG Asset Management US's Eli Lilly position peaked at $187M in Q2 2024.
  • 4,441 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on APG Asset Management US's 13F filing for Q4 2025, filed 12 Feb 2026.